Otros idiomas GeneOne Life Science, Inc.

Acciones

A011000

KR7011000007

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 28/06/2024			Varia. Cinco días.	Varia. 1 de enero.
2.045 ^KRW	-0,24 %		-5,76 %	-27,99 %

16/05	GeneOne Life Science, Inc. Resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
27/03	GeneOne Life Science, Inc. presenta los resultados del ejercicio finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05
GeneOne Life Science, Inc. announced that it has received KRW 3.6000014 billion in funding	28/03
GeneOne Life Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
GeneOne Life Science, Inc. announced that it expects to receive KRW 3.6000014 billion in funding	21/03
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
GeneOne Life Science, Inc. announced that it has received KRW 2.46998556 billion in funding	15/09/23
Gene One Life Science to Raise 2.5 Billion Won via Stock Sale	07/09/23
GeneOne Life Science, Inc. announced that it expects to receive KRW 2.46998556 billion in funding	06/09/23
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Gene One Life Science to Raise 80 Billion Won via Share Sale	17/05/23
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
Varicella Zoster Infections Pipeline Landscape Analysis of 03+ Companies by DelveInsight \| Leading Companies - Curevo Vaccine, GeneOne Life Science, SK Bioscience, and Others	04/10/22
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/08/22
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
GeneOne Life Science, Inc. announced that it has received KRW 11.7 billion in funding	15/04/22
GeneOne Life Science, Inc. announced that it expects to receive KRW 11.7 billion in funding	13/04/22
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	08/11/21
SK bioscience : S.Korea to begin producing Novavax COVID-19 vaccine as early as June	12/04/21
GeneOne Life Science : VGXI and Geneos Therapeutics Expand Partnership for Personalized Cancer Immunotherapies	17/03/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas GeneOne Life Science, Inc.

Acciones

A011000

KR7011000007

Otros idiomas

Filtros